Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 6/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | MAOA | P21397 | 4/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL869986 | 1.00 | GPR3 (0.40) | GPR3HPGDMAPTMAOAMAOB | |
| SCHEMBL25120914 | 0.80 | F12 (0.44) | GPR3MAPTHTTALDH1A1KDM4E | |
| SCHEMBL23704523 | 0.76 | MAOA (0.44) | GPR3HPGDMAPTMAOAMAOB | |
| SCHEMBL3724121 | 0.71 | ESR2 (0.39) | GPR3HPGDMAPTMAOAALDH1A1 | |
| SCHEMBL4804781 | 0.71 | CA12 (0.37) | GPR3HPGDMAPTMAOAALDH1A1 | |
| SCHEMBL341307 | 0.71 | MAOA (0.53) | HPGDMAPTMAOAMAOBCA2 | |
| Dibenzofuran SCHEMBL367550 | 0.71 | GPR3 (0.67) | GPR3HPGDMAPTMAOAALDH1A1 | |
| SCHEMBL17930625 | 0.70 | AHR (0.50) | GPR3HPGDMAPTMAOAALDH1A1 | |
| SCHEMBL869842 | 0.69 | KDM4E (0.46) | HPGDMAPTMAOAMAOBCA2 | |
| Dibenzofuran SCHEMBL11694595 | 0.67 | GPR3 (0.58) | GPR3HPGDMAPTMAOAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9062064-B2 | Heterocyclic compounds and the use thereof in electronic and optoelectronic components | NOVALED AG (DE) | 2015-06-23 | — | — | US | claimed |
| CN-102317406-A | Heterocyclic compounds and their use in electronic and optoelectronic components | NOVALED AG | 2012-01-11 | — | — | CN | claimed |
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | NOVALED AG (DE) | 2011-12-22 | — | — | US | claimed |
| WO-2010075836-A2 | HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN ELECTRONIC AND OPTOELECTRONIC COMPONENTS | NOVALED AG (DE) | 2010-07-08 | — | — | WO | claimed |
| US-11787965-B2 | Ink composition for forming an organic layer of a semiconductor | NOVALED GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| US-11787965-B2 | Ink composition for forming an organic layer of a semiconductor | NOVALED GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| US-11787965-B2 | Ink composition for forming an organic layer of a semiconductor | NOVALED GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| EP-3382770-B1 | INK COMPOSITION FOR FORMING AN ORGANIC LAYER OF A SEMICONDUCTOR | NOVALED GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| EP-3382770-B1 | INK COMPOSITION FOR FORMING AN ORGANIC LAYER OF A SEMICONDUCTOR | NOVALED GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| US-20200032093-A1 | Ink Composition for Forming an Organic Layer of a Semiconductor | NOVALED GMBH (DE) | 2020-01-30 | — | — | US | disclosed |
| EP-2789027-B1 | ORGANIC PHOTOVOLTAIC DEVICE | NOVALED GMBH (DE) | 2019-08-14 | — | — | EP | disclosed |
| EP-3382770-A1 | INK COMPOSITION FOR FORMING AN ORGANIC LAYER OF A SEMICONDUCTOR | Novaled GmbH (DE) | 2018-10-03 | — | — | EP | disclosed |
| US-20130320307-A1 | Organic Light Emitting Device | NOVALED AG (DE) | 2013-12-05 | — | — | US | disclosed |
| WO-2013083713-A1 | ORGANIC PHOTOVOLTAIC DEVICE | NOVALED AG (DE) | 2013-06-13 | — | — | WO | disclosed |
| CN-102971883-A | Organic light emitting device | NOVALED AG | 2013-03-13 | — | — | CN | disclosed |
| US-20120074392-A1 | Tandem White OLED | NOVALED AG (DE) | 2012-03-29 | — | — | US | disclosed |
| CN-102317406-A | Heterocyclic compounds and their use in electronic and optoelectronic components | NOVALED AG | 2012-01-11 | — | — | CN | disclosed |
| WO-2011157385-A2 | ORGANIC LIGHT EMITTING DEVICE | NOVALED AG (DE) | 2011-12-22 | — | — | WO | disclosed |
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | NOVALED AG (DE) | 2011-12-22 | — | — | US | disclosed |
| WO-2010075836-A2 | HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN ELECTRONIC AND OPTOELECTRONIC COMPONENTS | NOVALED AG (DE) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110309307-A1 | Heterocyclic Compounds and the Use Thereof in Electronic and Optoelectronic Components | TRPA1, SLC18A3, CYBA | GPR3 1321/4885HPGD 935/4885MAPT 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.